Bayesian Capital Management, LP Haemonetics Corp Transaction History

Bayesian Capital Management, LP

$838 Million
Q3 2024

A detailed history of Bayesian Capital Management, LP transactions in Haemonetics Corp stock. As of the latest transaction made, Bayesian Capital Management, LP holds 4,033 shares of HAE stock, worth $304,249. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,033

Previous 5,233 22.93%

Holding current value

$304,249

Previous $432,000 25.0%

% of portfolio

0.04%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$72.45 - $91.58 $86,940 - $109,896	-1,200 Reduced 22.93%	4,033 $324,000
Q2 2024 Aug 14, 2024	BUY	$81.24 - $97.37 $425,128 - $509,537	5,233 New	5,233 $432,000
Q4 2022 Feb 14, 2023	BUY	$73.85 - $86.14 $265,860 - $310,104	3,600 Added 101.61%	7,143 $561,000
Q3 2022 Nov 14, 2022	BUY	$63.3 - $78.66 $224,271 - $278,692	3,543 New	3,543 $262,000
Q2 2022 Aug 15, 2022	SELL	$49.27 - $66.08 $379,083 - $508,419	-7,694 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$43.77 - $63.22 $336,766 - $486,414	7,694 New	7,694 $486,000
Q3 2021 Nov 15, 2021	SELL	$57.6 - $70.59 $432,000 - $529,425	-7,500 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$51.81 - $118.56 $388,575 - $889,200	7,500 New	7,500 $500,000
Q3 2020 Nov 12, 2020	SELL	$75.65 - $93.58 $431,205 - $533,406	-5,700 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$84.96 - $118.91 $110,447 - $154,583	1,300 Added 29.55%	5,700 $510,000
Q1 2020 May 15, 2020	SELL	$74.34 - $121.82 $245,322 - $402,006	-3,300 Reduced 42.86%	4,400 $439,000
Q4 2019 Feb 14, 2020	BUY	$114.37 - $129.46 $480,354 - $543,732	4,200 Added 120.0%	7,700 $885,000
Q3 2019 Nov 13, 2019	BUY	$117.16 - $138.52 $410,060 - $484,820	3,500 New	3,500 $441,000
Q1 2019 May 14, 2019	SELL	$83.25 - $102.12 $603,895 - $740,778	-7,254 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$90.66 - $116.63 $262,914 - $338,227	2,900 Added 66.61%	7,254 $726,000
Q3 2018 Nov 14, 2018	SELL	$89.96 - $114.58 $926,587 - $1.18 Million	-10,300 Reduced 70.29%	4,354 $499,000
Q2 2018 Aug 14, 2018	BUY	$71.53 - $95.75 $404,430 - $541,370	5,654 Added 62.82%	14,654 $1.31 Million
Q1 2018 May 15, 2018	SELL	$60.72 - $74.41 $224,664 - $275,317	-3,700 Reduced 29.13%	9,000 $658,000
Q4 2017 Feb 12, 2018	BUY	$44.96 - $58.99 $570,992 - $749,173	12,700	12,700 $738,000

Others Institutions Holding HAE

# of Institutions

332

Shares Held

53.8M

Call Options Held

689K

Put Options Held

345K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.87B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Account

Bayesian Capital Management, LP Haemonetics Corp Transaction History